Dr Andrew McDowell graduated from Queens University, Belfast (QUB) with a BSc Hons degree and PhD in Biochemistry (1998). He then undertook post-doctoral studies in molecular medical microbiology at Belfast City Hospital, the School of Medicine, Dentistry and Biomedical Sciences at QUB (Centre of Infection & Immunity), and the Biological Research Centre of the Hungarian Academy of Sciences, Szeged (European Centre of Excellence).
He was appointed as a Lecturer In Stratified Medicine at Ulster University in 2013. Dr McDowell is also a Visiting Senior Research Fellow at the School of Pharmacy at QUB, and is a Fellow of the Higher Education Academy.
Dr McDowell has published widely and is an editor for the journals PLOSONE and BMC Microbiology (Clinical Microbiology and Vaccines section). He has secured significant grant funding as PI, and has a wide network of collaborators at both the national and international level, and established links with industry.
Dr McDowell’s research focuses on the role of the human microbiota and microbiome in health and disease, an area now at the forefront of personalised medicine.
He has a particular interest in the role of endogenous microbiota in the development of cancer, and with funding support from Prostate Cancer UK he has established a programme of research into the role of the anaerobic bacterium Propionibacterium acnes in the development of prostate disease, with the goal of identifying new therapeutic pathways to reduce prostate cancer incidence in men.
Dr McDowell also collaborates with other members of the Stratified Medicine team in relation to the role of the human microbiome in cardiovascular disease and mental health (depression). He has expertise in anaerobic bacteriology, biochemistry and molecular biology, including next generation sequencing, microbiomics, functional genomics, bioinformatics and phylogenetic analyses.
Dr McDowell teaches widely on the Stratified Medicine BSc and MSc degree programmes. He is module coordinator for the undergraduate module Genetic Inheritance and Omic Technologies (BIO124) and the postgraduate module Stratified Medicine and Healthcare Innovation (BIO832).
36th Japanese Congress of Sarcoidosis, Tokyo, Japan (6-8th October 2016). Symposium speaker: The ‘Jekyll and Hyde’ personality of Propionibacterium acnes in relation to human health and disease
Society for Anaerobic Microbiology, London. UK (2nd December 2013). Could Propionibacterium acnes infection of the prostate gland be an important, modifiable risk-factor for prostate cancer?
Stiefel (GlaxoSmithKline), North Carolina, USA (19th March 2013). Has population genetic analysis breathed new life into acne research?
David Geffen School of Medicine, UCLA, Los Angeles, USA (15th March 2013). Propionibacterium acnes as an underestimated cause of human disease.
University of Washington Medical Centre, Seattle, USA (13th March 2013). Laboratory Medicine Grand Rounds Lecture: Propionibacterium acnes as an underestimated cause of human disease.
Prostate Cancer UK, London (14th September, 2012). Understanding the role of bacteria in the aetiology of prostate cancer.
European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), London, (2nd April 2012). Symposium speaker: The Paradox of Propionibacterium acnes: benign commensal and virulent pathogen.
Dr McDowell also coordinates the marketing activities of Stratified Medicine and is a member of the School of Biomedical Sciences School Recruitment and Marketing Committee.
|Investigation of oral and blood microbiome shifts in patients with depression. Funded PhD Opportunity||Friday 7 February 2020||View Details|